Telix Pharmaceuticals Ltd. (AU:TLX) has released an update.
Telix Pharmaceuticals Limited has announced the application for quotation of 717,587 new fully paid ordinary shares on the ASX under the security code TLX, with the issue date set for April 9, 2024. This move, part of a transaction previously announced, could potentially interest investors looking for new opportunities in the healthcare sector.
For further insights into AU:TLX stock, check out TipRanks’ Stock Analysis page.
